Radiation necrosis following proton therapy successfully treated by low-dose bevacizumab in a patient with relapsed anaplastic ependymoma
Pediatr Blood Cancer
.
2018 Aug;65(8):e27088.
doi: 10.1002/pbc.27088.
Epub 2018 Apr 18.
Authors
Shoji Saito
1
,
Yosuke Miyairi
2
,
Masayuki Araya
3
,
Shoji Yomo
4
,
Haruki Kuwabara
2
,
Eriko Uchida
1
,
Tatsuo Watanabe
1
,
Takashi Kurata
1
,
Kazuo Sakashita
1
,
Hiroaki Shigeta
2
Affiliations
1
Department of Hematology and Oncology, Nagano Children's Hospital, Azumino, Japan.
2
Department of Neurosurgery, Nagano Children's Hospital, Azumino, Japan.
3
Proton Therapy Center, Aizawa Hospital, Matsumoto, Japan.
4
Gamma Knife Center, Aizawa Hospital, Matsumoto, Japan.
PMID:
29667785
DOI:
10.1002/pbc.27088
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Adult
Bevacizumab
Ependymoma*
Glioma*
Humans
Infant
Proton Therapy*
Trigeminal Neuralgia*
Substances
Bevacizumab